Close
Show

Research Insight

This section gives you a mored vivid idea of groundbreaking research currently happening globally which are capable of changing the way in which a lot happens in the industry.

Queen's University leading clinical trial on cell therapy treatment for COVID19 patients

Queen’s University leading clinical trial on cell therapy treatment for COVID19 patients

Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.This...
Oxford University Imaging Lab and Zegami comes together to target Cardiovascular disease

Oxford University Imaging Lab and Zegami comes together to target Cardiovascular disease

Zegami, the data visualisation company, has been appointed by Oxford University researchers at the Oxford Cardiovascular Clinical Research Facility to accelerate research into cardiovascular...
What Drugs Do with a Brain?

What Drugs Do with a Brain?

The brain is a complex body organ. It comprises a three-pound white and gray matter mass that is at the center of human activity....
Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell Regeneration

Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, together, cause the...
Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma

Much shorter radiation treatment found to be safe, effective for people with soft tissue...

A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found that treating soft tissue sarcoma with radiation over a significantly...
Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohns Disease

Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with...

Takeda Pharmaceutical Company Limited announced results from the phase 3 VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC)...
Resistant to Antibiotics

Imminence of New Gonorrhea Therapeutic Drugs is Evident as the Bacteria Grow Super Resistant...

According to a new study, the gonorrhea therapeutics market will reach US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over...

Road to Cell Death More Clearly Identified for Parkinson’s Disease

A pathway toward cellular death named for Thanatos identified by researchers as a key driver of nerve cell degradation in Parkinson’s diseaseDopamine neurons are...

Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma

A multi-institutional research team, led by investigators at Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, has identified specific states...

UCLA researchers develop mechanism for characterizing function of rare tumor cells

Scientists have long known that circulating tumor cells, rare cancer cells that are released into the bloodstream, have the potential to provide vital information...